🤖 AI & Machine Learning
Generative Biology: How AI-Designed Proteins are Entering Clinical Trials in April 2026
With the release of AlphaFold-Ultra and the success of de novo protein design, 2026 has brought us the 'Generative Biology' era. We analyze the first AI-designed antibody for a rare pancreatic cancer and why the 2020s-era 'drug discovery' model is dead.
Apr 02, 2026
Read More →